What are the risk factors for sleep-disordered breathing in patients with COPD (the “overlap syndrome")?
Effect of adenotonsillectomy on behavioral and cardiovascular outcomes in children with primary snoring
Effect of adenotonsillectomy on neurocognitive and behavioral outcomes in infants and and toddlers with obstructive sleep apnea syndrome.
Effectiveness of medications for cataplexy in children.
Does treatment of sleep apnea prevent cardiovascular disease?
Effect of anti-inflammatory medications (including nasal steroids and leukotriene antagonists) in children with obstructive sleep apnea syndrome, stratified for severity of OSAS as well as presence of atopy.
Long-term risk of recurrence of obstructive sleep apnea in children successfully treated with surgery during childhood.
Do patients with cardiovascular disease benefit from sleep apnea therapy?
Does alteration of sleep duration improve patient outcomes in sleep apnea?
Does treating sleep apnea benefit metabolic complications including non-alcoholic fatty liver disease?
Does treating sleep apnea benefit patients with obstructive lung disease?
The general area is that of preoperative risk management of sleep apnea patients undergoing major surgery. This field is burgeoning with clinical activity. A large amount of healthcare dollars are expended annually in order to detect sleep apnea and offer therapy that is of unproven value. Most all of the data is retrospective case series or a mixture of retrospective and prospective cohort studies. Yet, across the country, ...more »